Meetings organised on the occasion of Excellence in Paediatrics
Thursday 3 December (17:30–19:00)
Highlights in paediatric vaccination: medical needs and vision
Chair: Prof. Giovanni Gabutti (Italy)
| 17:30 | Welcome and introduction | Prof. Giovanni Gabutti |
| 17:33 | From efficacy to effectiveness: impact of human rotavirus vaccine | Prof. Carlo Giaquinto (Italy) |
| 18:08 | Are we really achieving optimal protection against pertussis? The C.O.P.E. proposal | Prof. Pierre Van Damme (Belgium) |
| 18:28 | Improving the control of varicella breakthroughs and outbreaks | Dr Vana Papaevangelou (Greece) |
| 18:38 | The burden of meningococcal disease and prevention strategies | Dr Jacqueline Miller (USA) |
| 18:58 | Symposium conclusion and close |
Organised by GSK Biologicals - Paediatric Vaccines
Friday 4 December (18.00–19.30)
Expanding the public health impact in bacterial respiratory diseases prevention
Chair: Prof. Paola Marchisio (Italy)
Co-chair: Prof. Markus Knuf (Germany)
| 18:00 | Welcome and introduction | Prof. Paola Marchisio |
| 18:05 | The 10-valent conjugated pneumococcal vaccine (PCV10): direct protection and preliminary data on indirect protection of pneumococcal disease | Prof. Markus Knuf (Germany) |
| 18:25 | The role of immunisation in prevention of acute otitis media in children | Dr Johannes Liese (Germany) |
| 18:45 | The potential public health benefit of Synflorix™. Example from the UK. |
Dr Baudouin Standaert (GSK, Belgium) |
| 19:15 | Q&A | Led by Chair |
| 19:30 | Symposium close |
Organised by GSK Biologicals - Synflorix™
